Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology: Trends in Molecular Medicine
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
NF‐κB and HIF crosstalk in immune responses - D'Ignazio - 2016 - The FEBS Journal - Wiley Online Library
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology: Trends in Molecular Medicine
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections | The Journal of Immunology
Tripterygium ingredients act on Th17. TGF-b/SMADs/RORgt,... | Download Scientific Diagram
The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24 - ScienceDirect
Cytokine production by Th17 cells in CF Pathway Map - PrimePCR | Life Science | Bio-Rad
The non-canonical NF-κB pathway in immunity and inflammation | Nature Reviews Immunology
TRIM25 Promotes TNF-α–Induced NF-κB Activation through Potentiating the K63-Linked Ubiquitination of TRAF2 | The Journal of Immunology
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies - ScienceDirect
Frontiers | NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients | Immunology
Th17/IL-17 induces endothelial cell senescence via activation of NF-κB/p53/Rb signaling pathway | Laboratory Investigation
The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis | Arthritis Research & Therapy | Full Text
Interferon regulatory factor 5 and nuclear factor kappa‐B exhibit cooperating but also divergent roles in the regulation of pro‐inflammatory cytokines important for the development of TH1 and TH17 responses - Stein -
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome | Nature Immunology
IL-17 and Th17 Cells in Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside | Immunology
NF-κB in inflammation and renal diseases | Cell & Bioscience | Full Text
T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation | PNAS
NF-κB control of T cell development | Nature Immunology
